This observation aligns with our previous findings [17] and reflects the fact that, despite carrying a compound mutation involving the catalytic subunit of this heterotrimeric complex, RNASEH2A-mutated AGS patients often exhibit a clinical phenotype more closely resembling that of healthy controls, though the underlying reasons are not yet fully understood. The gene discussed is RNASEH2A; the disease is Aicardi-Goutieres syndrome.